50881-044-08 : NDC 2026 Code

50881-044-08 : Ruxolitinib ( Jakafi Xr )

Additionally :

You can get information about “50881-044-08” NDC code in 50881-044-08 in HTML format

HTML | 50881-044-08 in TXT (Plain Text) format

TXT | 50881-044-08 in PDF (Portable Document Format)

PDF | 50881-044-08 in XML format

XML formats.

NDC Code : 50881-044-08 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50881-044-08",
    "PackageDescription": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08) ",
    "NDC11Code": "50881-0044-08",
    "ProductNDC": "50881-044",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Jakafi Xr",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ruxolitinib",
    "DosageFormName": "TABLET, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260501",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA217180",
    "LabelerName": "Incyte Corporation",
    "SubstanceName": "RUXOLITINIB",
    "StrengthNumber": "44",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-05-09",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260501",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}